Mike Duval represents public and privately held companies in corporate and securities matters, including private financings, public offerings, mergers and acquisitions, SEC reporting and corporate governance matters.
Download full bio
Duke University School of LawJD, 2017
University of ArizonaMA, Philosophy2014
University of Arizona BA, Philosophy2013
Neogene Therapeutics to Sell to AstraZeneca
November 30, 2022
+1 858 550 6106